New patent expiration for Siga Technologies drug TPOXX
Annual Drug Patent Expirations for TPOXX Tpoxx is a drug marketed by Siga Technologies and is included in two NDAs. […]
New patent expiration for Siga Technologies drug TPOXX Read Post »
Annual Drug Patent Expirations for TPOXX Tpoxx is a drug marketed by Siga Technologies and is included in two NDAs. […]
New patent expiration for Siga Technologies drug TPOXX Read Post »
Annual Drug Patent Expirations for NUVIGIL Nuvigil is a drug marketed by Cephalon and is included in one NDA. It
Annual Drug Patent Expirations for ABILIFY+MYCITE+KIT Abilify Mycite Kit is a drug marketed by Otsuka and is included in one
New patent expiration for Otsuka drug ABILIFY MYCITE KIT Read Post »
ABRAXANE (paclitaxel) Bristol-myers Patent: 8,314,156 Expiration: Jun 9, 2024 See More … For more information on how DrugPatentWatch can help
Drug Patent Expirations for the Week of June 9, 2024 Read Post »
Annual Drug Patent Expirations for ABRAXANE Abraxane is a drug marketed by Bristol-myers and is included in one NDA. It
New patent expiration for Bristol-myers drug ABRAXANE Read Post »
Annual Drug Patent Expirations for ILEVRO Ilevro is a drug marketed by Harrow Eye and is included in one NDA.
New patent expiration for Harrow Eye drug ILEVRO Read Post »
ILEVRO (nepafenac) Harrow eye Patent: 7,947,295 Expiration: Jun 8, 2024 See More … For more information on how DrugPatentWatch can
Drug Patent Expirations for the Week of June 2, 2024 Read Post »
Annual Drug Patent Expirations for NUZYRA Nuzyra is a drug marketed by Paratek Pharms Inc and is included in two
New patent expiration for Paratek Pharms drug NUZYRA Read Post »
Annual Drug Patent Expirations for ZONTIVITY Zontivity is a drug marketed by Xspire Pharma and is included in one NDA.
New patent expiration for Xspire Pharma drug ZONTIVITY Read Post »
Get fresh news and insights, drug patent expirations & more…